![](/img/cover-not-exists.png)
002 Switching treatments of etanercept biosimilar GP2015 with originator product does not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis
Griffiths, C.E., Reich, K., Thaçi, D., Gerdes, S., Arenberger, P., Kingo, K., Weglowska, J., Woehling, H.Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.098
Date:
October, 2017
File:
PDF, 240 KB
english, 2017